Vice President and Deputy Chief Academic Officer, Clinical and Interdisciplinary Research, The University of Texas MD Anderson Cancer Center
George Wilding, MD graduated with an MD from the University of Massachusetts Medical School where he also trained in Internal Medicine. He has a BS in Chemical Engineering and a BS in Biology from Tufts University, an MS in Pharmacology from Penn State University, and trained in Medical Oncology at the NCI. He served on the faculty of the University of Wisconsin-Madison from 1988 to 2015. Progressing from Assistant Professor to Professor of Medicine.
His research focuses in the laboratory and clinic on prostate carcinogenesis and the development of new therapies for advanced prostate cancer, with continuous federal peer reviewed funding for 30 plus years. He served as the Head of Hematology/Oncology for 18 years and as Director of the Carbone Cancer Center, an NCI designated comprehensive cancer center for 12 years. As Director, he built strong relations with academic cancer centers in China, Taiwan and South Korea.
Since 2015, Dr. Wilding has served as Vice President and Deputy Chief Academic Officer of Clinical and Interdisciplinary Research at The University of Texas MD Anderson Cancer Center. While overseeing the MD Anderson clinical research activities, he is very involved in its Global Academic Program and Moon Shots Program.